Drugs / oral contraceptive
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01798875 Comparator | Apr 2012 → Dec 2015 | polycystic ovary syndrome | Medical University of Gdansk | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oral contraceptive | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01798875 ↗ |
| Route | Oral | “oral contraceptive containing 35ug of ethynylestradiol and 2mg of cyproterone acetate (21 day regimen)” NCT01798875 ↗ |